Can cervical precancer heal on its own?
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This study watches to see if early precancerous cells (CIN 2 or 3) on the cervix can go away without treatment, especially in women under 40. It helps doctors understand who might avoid surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a cervical biopsy showing CIN 2 or CIN 3 (moderate to severe precancer).
- You are between 18 and 40 years old.
- Doctors can see the whole area where the cervix meets the cervical canal (the squamocolumnar junction).
- You are not pregnant.
- You do not have HIV or a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how having multiple types of HPV virus affects the development of abnormal cervical cells (called CIN). It may help doctors understand why some people are more at risk and could lead to better prevention.
This trial compares two ways of managing CIN 2, a moderate precancerous change on the cervix. One option is a new procedure that uses argon plasma (a type of energized gas) to treat the area; the other is careful monitoring without immediate treatment, to see if one works better at clearing the abnormal cells.
This study looks at how shared decision-making affects women's choices when they have abnormal cervical cells that may need treatment. It may help you feel more involved in choosing the right treatment for you.
This study looks at better ways to manage early precancerous changes in the cervix (called high-grade lesions) without surgery. It aims to find which approaches work best for women who have not been vaccinated against HPV.
This trial checks whether “therapy abstention” (not treating right away) and close monitoring is safe for certain high-grade cervical cell changes. It may help some people avoid immediate procedures while still catching any progression early.
This study looks at tissue samples from cervical biopsies to find markers that might help predict whether precancerous changes could become cancer. It may help doctors better understand and manage cervical precancer.
Hear when a new HPV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.